• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Calcium antagonists as a new treatment modality in hypertension.

作者信息

Laragh J H

机构信息

New York Hospital-Cornell Medical Center, New York, New York.

出版信息

Angiology. 1988 Jan;39(1 Pt 2):100-5.

PMID:3277491
Abstract

The long-term vasoconstriction which is characteristic of human hypertension may be mediated by entirely different mechanisms in various hypertensive patients. In some whose hypertension is related to activation of the renin-angiotensin-aldosterone control system, appropriate antirenin therapy is effective. Recent studies indicate that calcium ions may play a special role in the etiology of low-renin essential hypertension. Specific abnormalities in calcium and magnesium metabolism which are related to deviations in the renin system have been identified. Antihypertensive therapy with calcium antagonist drugs such as nitrendipine appears to be most effective in patients with low levels of renin activity and serum ionized calcium. These observations support the concept of the heterogeneity of human hypertension and could represent a significant step towards more specific antihypertensive drug therapy.

摘要

相似文献

1
Calcium antagonists as a new treatment modality in hypertension.
Angiology. 1988 Jan;39(1 Pt 2):100-5.
2
Clinical parameters of concern in the pathology and treatment of hypertension.
J Clin Hypertens. 1986 Sep;2(3 Suppl):1S-11S.
3
Recognizing and treating two types of long-term vasoconstriction in hypertension.认识并治疗高血压中的两种长期血管收缩类型。
Kidney Int Suppl. 1988 Sep;25:S162-74.
4
The significance of calcium and calcium channel blockade in essential hypertension.
J Hypertens Suppl. 1985 Dec;3(3):S541-4.
5
[The specificity of the hypotensive effect of calcium antagonists in hypertension].[钙拮抗剂在高血压中降压作用的特异性]
Ter Arkh. 1991;63(9):97-100.
6
[The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].[钙拮抗剂长期治疗动脉高血压对糖尿病患者肾素-血管紧张素-醛固酮系统的影响。低肾素性低醛固酮血症]
Vnitr Lek. 1995 Oct;41(10):661-6.
7
Comparison of calcium-entry blockers and diuretics in the treatment of hypertensive patients.钙通道阻滞剂与利尿剂治疗高血压患者的比较。
Circulation. 1987 Jun;75(6 Pt 2):V170-3.
8
Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease.钙通道阻滞剂和肾素-血管紧张素系统阻滞剂对高血压血管疾病血管内及神经激素机制的影响。
Am J Hypertens. 2008 Oct;21(10):1076-85. doi: 10.1038/ajh.2008.258. Epub 2008 Aug 28.
9
Calcium antagonists, firstline partners for betablockers in hypertension.钙拮抗剂,高血压治疗中β受体阻滞剂的一线搭档。
Z Kardiol. 1984;73 Suppl 2:95-9.
10
Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.双重钙通道及肾素-血管紧张素系统阻断对高血压血管疾病的靶向作用机制
J Hum Hypertens. 2007 Oct;21(10):770-9. doi: 10.1038/sj.jhh.1002254. Epub 2007 Jun 28.